Last update 01 Nov 2024

Purdue Neuroscience Co.

Subsidiary Company|
Connecticut, United States

Overview

Basic Info

Introduction
Purdue Neuroscience Co. is a pharmaceutical company based in Stamford, CT, and it operates as a subsidiary of Purdue Pharma LP. The company's primary focus is on the development, production, and marketing of pharmaceutical products.

Related

3
Drugs associated with Purdue Neuroscience Co.
ACEA-2085
Target
AMPA receptor x GlyR
Mechanism
AMPA receptor antagonists [+1]
Active Org.-
Originator Org.
Purdue Neuroscience Co.
Active Indication-
Inactive Indication
Pain
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
Co-60549
Target
GABAA receptor
Mechanism
GABAA receptor antagonists
Active Org.-
Originator Org.
Purdue Neuroscience Co.
Active Indication-
Inactive Indication
Anxiety Disorders
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
Co-152791
Target
GABAA receptor
Mechanism
GABAA receptor positive allosteric modulators
Active Org.-
Originator Org.
Purdue Neuroscience Co.
Active Indication-
Inactive Indication
Epilepsy
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Purdue Neuroscience Co.
Login to view more data
0 Patents (Medical) associated with Purdue Neuroscience Co.
Login to view more data
100 Deals associated with Purdue Neuroscience Co.
Login to view more data
100 Translational Medicine associated with Purdue Neuroscience Co.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 19 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
3
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Co-60549
 ( GABAA receptor )		Anxiety Disorders
More
Discontinued
Co-152791
 ( GABAA receptor )		Epilepsy
More
Discontinued
ACEA-2085
 ( AMPA receptor x GlyR )		Pain
More
Discontinued
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free